Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus.
J Extracell Vesicles
; 10(2): e12050, 2020 12.
Article
en En
| MEDLINE
| ID: mdl-33391636
ABSTRACT
SARS-CoV-2 entry is mediated by binding of the spike protein (S) to the surface receptor ACE2 and subsequent priming by host TMPRSS2 allowing membrane fusion. Here, we produced extracellular vesicles (EVs) exposing ACE2 and demonstrate that ACE2-EVs are efficient decoys for SARS-CoV-2 S protein-containing lentivirus. Reduction of infectivity positively correlates with the level of ACE2, is much more efficient than with soluble ACE2 and further enhanced by the inclusion of TMPRSS2.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Enzima Convertidora de Angiotensina 2
/
COVID-19
Límite:
Humans
Idioma:
En
Revista:
J Extracell Vesicles
Año:
2020
Tipo del documento:
Article